STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study

NCT01181505 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Genotype Guided(HNF4a)
Healthy Subjects

Interventions

DRUG: Tolterodine

Sponsor

Inje University